Human respiratory syncytial virus (HRSV) is one of the most important causes of acute respiratory infections (ARI) in young children. HRSV diagnosis is based on the detection of the virus in respiratory specimens. Nasopharyngeal swabbing is considered the preferred method of sampling, although there is limited evidence of the superiority of nasopharyngeal swabs (NPS) over the less invasive nasal (NS) and throat (TS) swabs for virus detection by real-time reverse transcription quantitative polymerase chain reaction (RT-qPCR). In the current study, we compared the three swabbing methods for the detection of HRSV by RT-qPCR in children hospitalized with ARI at Mahosot Hospital, Vientiane, Laos. In 2014, NS, NPS, and TS were collected from 288 children. All three samples were tested for HRSV by RT-qPCR; 141 patients were found positive for at least one sample. Almost perfect agreements (κ > 0.8) between the swabs, compared two by two, were observed. Detection rates for the three swabs (between 93% and 95%) were not significantly different, regardless of the clinical presentation. Our findings suggest that the uncomfortable and technically more demanding NPS method is not mandatory for HRSV detection by RT-qPCR.
| INTRODUCTION
Human respiratory syncytial virus (HRSV) is a common respiratory pathogen in children under the age of 5 years. In 2015, there were estimated to be 33.1 million new episodes of HRSV-associated acute lower respiratory infections worldwide, of which 3.2 million were hospitalized and 59 600 patients died. 1 HRSV diagnosis is based on the detection of the virus in respiratory specimens using cell culture, immunofluorescence, immunoenzymatic, or molecular assays. During the past decade, polymerase chain reaction (PCR), a fast and accurate detection tool, has been widely used in the diagnosis and is often chosen over conventional methods for the detection of respiratory pathogens. 2 Collection of nasopharyngeal swabs (NPS) is considered the preferred sampling method for the detection of respiratory viruses, 3 although it requires experienced staff and can be uncomfortable, especially for young children. There is limited evidence of the superiority of NPS over the less invasive nasal (NS) and throat (TS) swabs for virus detection by real-time PCR, with only a few studies evaluating HRSV detection in children [4] [5] [6] [7] and two including NS. 6, 7 We are not aware of studies that have compared all three sampling methods.
In 2014, we conducted a study on children (<5-year-old)
hospitalized at Mahosot Hospital, Vientiane, Laos, with an acute respiratory infection (ARI). 8 Three different samples (NS, TS, and NPS) were collected from a large proportion of these patients. Since
HRSV was one of the most common pathogens detected, this gave us the opportunity to compare the performance of these three sampling techniques for the detection of HRSV by real-time reverse transcription quantitative polymerase chain reaction (RT-qPCR).
| MATERIALS AND METHODS

| Specimen collection
From December 2013 to December 2014, 383 children younger than 5 years of age, with a clinical presentation of ARI were enrolled, as previously described. 8 At inclusion, samples were collected at the same time in the following sequence: TS, NS, then NPS. They were available for 288 (75.2%) patients who were included in this study. NS and TS were placed separately in 1 mL viral transport medium (Sigma Virocult
[MWE]), Corsham, England vials. NPS was placed in 1 mL of skim-milk tryptone glucose glycerol medium (STGG), to allow subsequent bacterial and viral investigations from the same sample. 9 Virocult vials and STGG were transported to the laboratory within 2 hours in a cool box. Swabs were squeezed, and the media were aliquoted and stored at −80°C before performing the laboratory assays. 
| HRSV quantification
RNA (4.93·10 6 copies/μL, quantified by RT-qPCR using a quantified synthetic RNA prepared as previously described characteristics of the patients are presented in supplemental data addition, the HRSV viral load detected in NS was not significantly different to that in NPS (P > .05, t test), but significantly higher than that in TS (P < .001, t test).
Our findings are in accordance with previous publications.
Grijalva et al 6 found good agreement between NS and NPS for the detection of HRSV. However, NPS was not systematically investigated for all patients and the study included only 36 HRSV patients.
Dawood et al 7 observed high detection rates for both NS and TS (98% and 93%, respectively) for the detection of 343 HRSV patients from 703 hospitalized children. However, they did not investigate NPS.
We also investigated whether the choice of the sampling method should be based on particular patient characteristics, such as young age, specific respiratory symptoms, or signs of severity. For this, the detection rates of the three swabs were calculated and compared within different groups of patients sharing the same characteristics.
No significant difference was observed between the three different F I G U R E 1 Detection rate of the three swabs tested for the detection of HRSV by RT-qPCR according to patient characteristics. Only the characteristics which were observed in more than 30 HRSV-positive patients are displayed.
#
Detection rate of each swab for the detection of HRSV by RT-qPCR calculated over the total number of positive patients (positive in at least one of the three swabs tested).
•"PCV13 received" if they had received at least two doses of vaccine for children less than 1-year-old or at least one dose of vaccine for children between 1-to 2-year old. *wet season: from May to October. ■Low birth weight: defined by the World Health Organisation (WHO) as weight at birth less than 2500 g. ❖Fever: defined as body temperature 38°C or higher per axilla. ➤HRSV-positive patients = positive for HRSV by RT-qPCR for at least one of the three swabs tested. ♣Pneumonia and severe pneumonia were defined according to WHO criteria: children who presented with cough or difficulty breathing and had fast breathing (aged 2-11 months: ≥50 breaths/minute, aged 1-4 years: ≥40 breaths/min) or chest indrawing, were classified as having pneumonia; children who presented with cough or difficulty breathing and had at least one of the following criteria were classified as severe pneumonia: oxygen saturation 90% or lesser , while breathing room air, or central cyanosis; severe respiratory distress; signs of pneumonia with a general danger sign (inability to breastfeed or drink, lethargy or reduced level of consciousness, convulsions, vomiting). Children younger than 2-month old who presented with cough or difficulty breathing and fast breathing (≥60 breaths/min) were classified as severe pneumonia. HRSV, human respiratory syncytial virus; RT-qPCR, reverse transcription quantitative polymerase chain reaction swabs for any of the patient groups tested. However, most of the patients included in this study had coryza (90%), so the values of the detection rate for the three swabs could not be established with accuracy for the seven HRSV patients with no coryza.
Accurate diagnosis is closely linked to the quality of the sample collection, which could be impacted, amongst other things, by the practicability of the sampling method and its acceptance by the patient and their family. Our study provides evidence that a simple and painless NS sampling can be used with a high degree of accuracy for the detection of HRSV by RT-qPCR in children hospitalized for ARI presenting with coryza. This is of particular importance, especially in young children for whom NPS sampling is unpleasant and can be challenging when performed by less experienced staff. When available, simple and painless methods should be prioritized after appropriate validation. However, our study was limited to the assessment of HRSV detection in children less than 5 years of age, therefore extrapolation of our findings to other age groups and/or other respiratory viruses would require additional investigations.
We conclude that performing NS sampling is appropriate for the molecular detection of HRSV in children under the age of 5 years. 
